A Review on Estimation of Hb Percentage and Electrophoretic Pattern in Low Hb Count Cancer Patient

Authors

  • Prince Sen
  • Seema Goyal
  • Alka Tiwari
  • Sameena Akhtar
  • Alibha Rawat
  • N. Ganesh

Keywords:

Cancer, haemoglobin percentage, Hb electrophoresis, low Hb count, thalassemia

Abstract

Haemoglobin is a protein in the red blood cells that carry oxygen. Hb evaluation is a fast, valid and trustworthy method to detect blood deficiency. Direct cyanmethemoglobin has been the gold standard method for Hb estimation but there are many other methods available as well, for example, haemoglobin colour scale, Sahli method, Lovibond-Drabkin method, Tallqvist technique, copper sulphate method, HemoCue, automated haematology analysers and complete blood count to name a few. Each method has its own benefits and disadvantages. Haemoglobin electrophoresis is another cost- effective and user friendly method to analyse Hb. Several hemoglobinopathies are known that are serious health hazards to human kind like anaemia or thalassemia. Cancer patients frequently experience anaemia as a recognized complication. It is either caused by the tumour itself or by the chemotherapy regimen used. The assessment and monitoring of Hb concentration in cancer patients is an important part of cancer management. The current review compiles studies done in the analysis of Hb with special reference to cancer.

References

Pranav Kumar, Mina U. Biotechnology A problem approach. 3rd Edn. New Delhi, India: Pathfinder Publication; 2015. [Internet]. Academia.edu. 2015 [cited 2023 Jul 17]. Available from: https://www.academia.edu/19269694/Biotechnology_A_problem_approach

Jan U, Parveen S, Hussain Q. Preparation of Stable and Highly Active Hemoglobin by Using Antiglycosylspecific Hemoglobin Polyclonal Antibodies. Int J Sci Res Publ. 2013; 3(4): 1–5. [Internet]. Available from: https://www.ijsrp.org/research-paper-0413/ijsrp-p1664.pdf. [cited 2023 Jul 17]

Henry DH. Parenteral iron therapy in cancer associated anemia hematology. Am Soc Hemotal Educ Program. 2010; 2010: 315–356.

Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review. Cancer. 2001; 91(12): 2214–2221.

Fabiana Busti, Marchi G, Ugolini S, Castagna A, Domenico Girelli. Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy. Pharmaceuticals (Basel). 2018 Sep 30; 11(4): 94. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315653/ [cited 2023 Jul 17]

Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014; 89(2): 203–212.

An Ran et al. Point-of-care microchip electrophoresis for integrated anemia and hemoglobin variant testing. Lab on a Chip. 2021; 21: 3863–3875. DOI: https://doi.org/10.1039/d1lc00371b.

Harper P, Littlewood T. Anaemia of cancer: Impact on patient fatigue and long-term outcome. Oncology. 2005; 69(Suppl 2): 2–7.

Van Eeden R, Rapoport BL. Current trends in the management of anaemia in solid tumours and Haematological malignancies. Curr Opin Support Palliat Care. 2016; 10(2): 189–194.

Kathleen Deska Pagana, Timothy J. Pagana, Theresa Noel Pagana. (2021). Mosby’s® Diagnostic and Laboratory Test Reference. 15th Edn. Elsevier Education Portal [Online] Available from https://evolve.elsevier.com/cs/product/9780323675192?role=student.

Bushra Khanam, Sudhir Maurya, Prakhar Gupta, Shainila Shaikh. A Study on Hemoglobin Electrophoresis Profile in Patients with Moderate to Severe Anemia. Int J Contemp Med Res. 2018 Mar; 5(3): C21–C24. ISSN (Online): 2393–915X; (Print): 2454–7379 | ICV: 77.83.

Knight K, Wade S, Balducci L. Prevalence and outcomes of anaemia in cancer: a systematic review of the literature. Am J Med. 2004 Apr 5; 116(Suppl 7A): 11S–26S.

Robert Pirker, Melissa Pirolli, Jane Quigley, Scott Hulnick, Jason Legg, Helen Collins, Johan Vansteenkiste. Hemoglobin decline in cancer patients receiving chemotherapy without an erythropoiesis-stimulating agent. Support Care Cancer. 2013; 21(4): 987–992.

Elliott S, Pham E, Macdougall IC. Erythropoietins: A common mechanism of action. Exp Hematol. 2008 Dec; 36(12): 1573–84.

Julia Bohlius, Kari Bohlke, Roberto Castelli, Benjamin Djulbegovic, Lustberg Maryam B, Massimo Martino, Giannis Mountzios, Namrata Peswani, Laura Porter, Tanaka Tiffany N, Gianluca Trifirò, Hushan Yang, Alejandro Lazo-Langner. Management of cancer-associated anemia with Erythropoiesis-Stimulating Agents: ASCO/ASH clinical practice guideline update. Blood Adv. 2019 Apr 23; 3(8): 1197–1210.

Dayakar S, Rani DS, Babu SJ, Srilatha K, Jayanthi U, Goud KI, Jain D, Raina V. Increasing role of cytogenetics in pediatric practice. Genetic testing and molecular biomarkers. 2010 Apr 1; 14(2): 197–204.

Downloads

Published

2023-09-05

Issue

Vol. 12 No. 1 (2023)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.